Many Bright Ideas Technologies (MBGNF) Stock Price, News & Analysis

Company Overview

Many Bright Ideas Technologies Inc. does not have significant operations. It was previously engaged in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $0.01 to $0.01
• 50-Day Range: $0.01 to $0.01
• 52-Week Range: $0.01 to $0.01
• Volume: N/A
• Average Volume: 600 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MBGNF Stock Analysis - Frequently Asked Questions

How have MBGNF shares performed this year?

Many Bright Ideas Technologies' stock was trading at $0.01 on January 1st, 2025. Since then, MBGNF stock has increased by 0.0% and is now trading at $0.01.
View the best growth stocks for 2025 here.

How were Many Bright Ideas Technologies' earnings last quarter?

Many Bright Ideas Technologies Inc. (OTCMKTS:MBGNF) announced its quarterly earnings data on Friday, November, 29th. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Many Bright Ideas Technologies?

Shares of MBGNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/29/2013
• Today: 5/23/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MBGNF
• CIK: N/A
• Web: www.medbiogene.com
• Phone: (604) 732-7332
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A